Peter Dowd - Alert Sample

Alert Sample

View the Parallel Parliament page for Peter Dowd

Information between 5th November 2025 - 25th November 2025

Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.

Division Votes
5 Nov 2025 - Public Authorities (Fraud, Error and Recovery) Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 264 Labour Aye votes vs 1 Labour No votes Tally: Ayes - 268 Noes - 80
5 Nov 2025 - Employment Rights Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 285 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 311 Noes - 152
5 Nov 2025 - Employment Rights Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 280 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 310 Noes - 150
5 Nov 2025 - Employment Rights Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 282 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 308 Noes - 153
5 Nov 2025 - Employment Rights Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 282 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 310 Noes - 155
5 Nov 2025 - Employment Rights Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 284 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 312 Noes - 151
12 Nov 2025 - Energy - View Vote Context Peter Dowd voted No - in line with the party majority and in line with the House One of 315 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 97 Noes - 336
12 Nov 2025 - Taxes - View Vote Context Peter Dowd voted No - in line with the party majority and in line with the House One of 306 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 101 Noes - 316
13 Nov 2025 - Planning and Infrastructure Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 240 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 244 Noes - 132
13 Nov 2025 - Planning and Infrastructure Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 249 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 252 Noes - 130
13 Nov 2025 - Planning and Infrastructure Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 238 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 250 Noes - 133
13 Nov 2025 - Planning and Infrastructure Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 251 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 254 Noes - 129
13 Nov 2025 - Planning and Infrastructure Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 252 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 257 Noes - 128
13 Nov 2025 - Planning and Infrastructure Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 254 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 268 Noes - 78
13 Nov 2025 - Planning and Infrastructure Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 251 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 255 Noes - 128
13 Nov 2025 - Planning and Infrastructure Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 240 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 264 Noes - 125
13 Nov 2025 - Planning and Infrastructure Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 250 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 254 Noes - 135
17 Nov 2025 - Biodiversity Beyond National Jurisdiction Bill - View Vote Context Peter Dowd voted No - in line with the party majority and in line with the House One of 305 Labour No votes vs 1 Labour Aye votes Tally: Ayes - 143 Noes - 318
17 Nov 2025 - Biodiversity Beyond National Jurisdiction Bill - View Vote Context Peter Dowd voted No - in line with the party majority and in line with the House One of 304 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 147 Noes - 318
18 Nov 2025 - Northern Ireland Troubles Bill - View Vote Context Peter Dowd voted No - in line with the party majority and in line with the House One of 311 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 165 Noes - 327
18 Nov 2025 - Northern Ireland Troubles Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 310 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 320 Noes - 105
19 Nov 2025 - Border Security, Asylum and Immigration Bill - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 306 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 326 Noes - 92
20 Nov 2025 - Deferred Division - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 312 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 376 Noes - 16
20 Nov 2025 - Telecommunications - View Vote Context Peter Dowd voted Aye - in line with the party majority and in line with the House One of 312 Labour Aye votes vs 0 Labour No votes Tally: Ayes - 376 Noes - 16
24 Nov 2025 - English Devolution and Community Empowerment Bill - View Vote Context Peter Dowd voted No - in line with the party majority and in line with the House One of 304 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 99 Noes - 367
24 Nov 2025 - English Devolution and Community Empowerment Bill - View Vote Context Peter Dowd voted No - in line with the party majority and in line with the House One of 300 Labour No votes vs 7 Labour Aye votes Tally: Ayes - 74 Noes - 311
24 Nov 2025 - English Devolution and Community Empowerment Bill - View Vote Context Peter Dowd voted No - in line with the party majority and in line with the House One of 306 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 158 Noes - 318
24 Nov 2025 - English Devolution and Community Empowerment Bill - View Vote Context Peter Dowd voted No - in line with the party majority and in line with the House One of 302 Labour No votes vs 0 Labour Aye votes Tally: Ayes - 57 Noes - 309

Written Answers
Cannabis: Medical Treatments Asked by: Peter Dowd (Labour - Bootle) Tuesday 25th November 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support and fund clinical trials aimed at achieving licensing and NHS access for complex, cannabis-based medicines used in the treatment of severe, drug-resistant epilepsy in children. Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care) The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is funding two trials to investigate the safety and efficacy of cannabinoid treatments for drug-resistant epilepsy in both adults and children. Further detail on the trials can be found on the NIHR’s website, at the following link: https://fundingawards.nihr.ac.uk/award/NIHR131309 The Department is committed to ensuring that all patients, including those with epilepsy, have access to cutting-edge clinical trials and innovative, lifesaving treatments. We are working to fast-track clinical trials to drive global investment into life sciences, improve health outcomes, and accelerate the development of the medicines and therapies of the future, including treatments for epilepsy.
Cannabis: Medical Treatments Asked by: Peter Dowd (Labour - Bootle) Tuesday 25th November 2025 Question to the Department of Health and Social Care: To ask the Secretary of State for Health and Social Care, whether he plans to bring responsibility for medical cannabis policy and governance to his Department in line with Schedule 2 medicines. Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care) The Home Office is the lead department for controlled drug legislation, whilst the Department of Health and Social Care and its Arm's Length Bodies lead on healthcare and the regulation of medicines. This framework applies to all drugs under Schedules 1 to 5 of the Misuse of Drugs Regulations 2001, including cannabis-based products for medicinal use. The Government has no plans to change this. The Department of Health and Social Care and the Home Office work closely with other system partners in developing and reviewing the policy on controlled drugs in healthcare, including cannabis-based products for medicinal use.

Written Answers

Cannabis: Medical Treatments
Asked by: Peter Dowd (Labour - Bootle)
Tuesday 25th November 2025

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support and fund clinical trials aimed at achieving licensing and NHS access for complex, cannabis-based medicines used in the treatment of severe, drug-resistant epilepsy in children.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Department commissions research through the National Institute for Health and Care Research (NIHR). The NIHR is funding two trials to investigate the safety and efficacy of cannabinoid treatments for drug-resistant epilepsy in both adults and children. Further detail on the trials can be found on the NIHR’s website, at the following link:

https://fundingawards.nihr.ac.uk/award/NIHR131309

The Department is committed to ensuring that all patients, including those with epilepsy, have access to cutting-edge clinical trials and innovative, lifesaving treatments. We are working to fast-track clinical trials to drive global investment into life sciences, improve health outcomes, and accelerate the development of the medicines and therapies of the future, including treatments for epilepsy.

Cannabis: Medical Treatments
Asked by: Peter Dowd (Labour - Bootle)
Tuesday 25th November 2025

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he plans to bring responsibility for medical cannabis policy and governance to his Department in line with Schedule 2 medicines.

Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)

The Home Office is the lead department for controlled drug legislation, whilst the Department of Health and Social Care and its Arm's Length Bodies lead on healthcare and the regulation of medicines. This framework applies to all drugs under Schedules 1 to 5 of the Misuse of Drugs Regulations 2001, including cannabis-based products for medicinal use. The Government has no plans to change this.

The Department of Health and Social Care and the Home Office work closely with other system partners in developing and reviewing the policy on controlled drugs in healthcare, including cannabis-based products for medicinal use.

MP Financial Interests
17th November 2025 Peter Dowd (Labour - Bootle) 4. Visits outside the UK International visit to Italy between 05 October 2025 and 11 October 2025 Source

Peter Dowd mentioned

Parliamentary Debates
Draft Victims and Prisoners Act 2024 (Permitted Disclosures) Regulations 2025 10 speeches (2,085 words) Wednesday 12th November 2025 - General Committees Ministry of Justice